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ABSTRACT
Lamins are the main components of the nucleoskele-
ton. Whereas their 3D organization was recently de-
scribed using cryoelectron tomography, no struc-
tural data highlights how they interact with their part-
ners at the interface between the inner nuclear en-
velope and chromatin. A large number of mutations
causing rare genetic disorders called laminopathies
were identified in the C-terminal globular Igfold do-
main of lamins A and C. We here present a first struc-
tural description of the interaction between the lamin
A/C immunoglobulin-like domain and emerin, a nu-
clear envelope protein. We reveal that this lamin A/C
domain both directly binds self-assembled emerin
and interacts with monomeric emerin LEM domain
through the dimeric chromatin-associated Barrier-
to-Autointegration Factor (BAF) protein. Mutations
causing autosomal recessive progeroid syndromes
specifically impair proper binding of lamin A/C do-
main to BAF, thus destabilizing the link between
lamin A/C and BAF in cells. Recent data revealed
that, during nuclear assembly, BAF’s ability to bridge
distant DNA sites is essential for guiding membranes
to form a single nucleus around the mitotic chromo-
some ensemble. Our results suggest that BAF inter-
action with lamin A/C also plays an essential role,
and that mutations associated with progeroid syn-
dromes leads to a dysregulation of BAF-mediated
chromatin organization and gene expression.
INTRODUCTION
Laminopathies are rare genetic disorders caused by mu-
tations in genes encoding lamins or by abnormalities in
the processing of lamin A (1). They display a large vari-
ety of clinical symptoms including cardiomyopathy, mus-
cular dystrophy, lipodystrophy, mandibuloacral dysplasia,
restrictive dermopathy, peripheral neuropathy, and prema-
ture ageing. A major fraction of the disease-causing muta-
tions comprises single point mutations with poorly under-
stood functional implications. Most of them are distributed
all along the LMNA gene coding for both prelamin A and
lamin C. These two proteins are, together with lamins B1
and B2, essential components of the nucleoskeleton. They
share an N-terminal region of 566 residues, and whereas
lamin C only possesses six additional specific C-terminal
residues, prelamin A presents 98 additional residues, is far-
nesylated, carboxymethylated and then cleaved to become
mature lamin A. Disease-causing mutations are observed
in the large region common to lamins A and C (lamin
A/C) as well as in the lamin A specific C-terminal region
(2). At the cellular level, lamins A and C form filaments
that are mainly present at the nuclear periphery but are
also observed in the nucleoplasm (3). Laminopathies are
characterized by nuclear morphological abnormalities and
an altered pattern of heterochromatin distribution that is
more severe in progeroid syndromes, includingHutchinson-
Gilford progeria syndrome (HGPS), mandibuloacral dys-
plasia (MAD), atypical-Werner syndrome (WS) and restric-
tive dermopathy (RD) (4,5). The lamin filament network
interacts with chromatin at different stages of the cell cy-
cle: in ana-telophase, lamin A and C dimers are recruited at
the core regions of sister chromosomes; in interphase cells,
they relocalize both at the nuclear envelope and within the
nucleoplasm, where lamins A and C provide anchor points
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for chromatin (6–9). The complex molecular organization
of the nuclear envelope, nucleoskeleton and their interface
with chromatin was recently described using cryo-electron
tomography (10,11). Within the densely packed environ-
ment observed close to the nuclear envelope, only nuclear
pores, lamin filaments and chromatin could be recognized.
Lack of high resolution 3D structures for proteins anchored
at the inner nuclear membrane as well as complexes be-
tween these proteins, the lamina and chromatin still pre-
cludes any further description of the nuclear periphery ar-
chitecture and of the structural defects caused by mutations
in the LMNA gene coding for lamins A and C.
We set out to understand how the C-terminal
immunoglobulin-like (Igfold) domain of lamin A/C
interacts with the inner nuclear membrane protein
emerin and the chromatin-associated protein Barrier-to-
Autointegration Factor (BAF). Indeed, a large number
of disease-causing mutations were identified in this lamin
Igfold domain (12,13). Mutations causing muscle diseases
affect residues of the hydrophobic core, suggesting that
destabilization of the lamin A/C Igfold domain is re-
sponsible for these diseases (13). Mutations causing either
lipodystrophies or progeroid syndromes involve residues
localized on two different solvent-exposed sites of the
lamin A/C Igfold domain, suggesting that these accessible
regions are binding sites for unknown lamin partners and
that disruption of these binding events cause the diseases
(12–14). Lamin A/C binds to the inner nuclear membrane
protein emerin, as shown by blot overlay, coimmunopre-
cipitation and yeast 2-hybrid assays (15–17). Moreover, the
tail region of lamin A/C (residues 384–566, comprising the
Igfold domain) is responsible for emerin binding (17,18).
The central region of emerin (residues 70–178) is essential
for lamin binding (15,18), and its N-terminal domain
(residues 1–45, the LEM domain) interacts with BAF, as
shown by a panel of techniques going from blot overlay and
coimmunoprecipitation assays to X-ray crystallography
analyses (15,19).
The structural inter-dependence of lamins, emerin and
BAF was revealed by downregulating either lamins A and
C or BAF or the LEM domain proteins emerin and LEM2
in Caenorhabditis elegans embryos. If any one component
was missing, the other two failed to co-assemble, with se-
vere consequences for mitotic spindle assembly and posi-
tioning (20), mitotic chromosome segregation and postmi-
totic nuclear assembly (21,22). In vitro experiments revealed
that human lamin A binds weakly (Kd of 1 M) but di-
rectly to BAF and that lamin A and BAF simultaneously
bind to emerin (23). Moreover, BAF enhances binding of
prelamin A tails to emerin (24). Finally, during nuclear as-
sembly, BAF enriches around the mitotic chromosome en-
semble, and its ability to bridge distant DNA sites is essen-
tial for guiding membranes to form a single nucleus (25).
We now demonstrate that emerin oligomerization regu-
lates direct lamin A/C binding, and that emerin monomer
also interacts with lamin A/C through BAF. We present
the 3D structure of a complex involving lamin A/C, emerin
and BAF. We propose a model in which BAF dimer bound
to two DNA molecules interacts on one side with emerin
and on the other side with lamin A/C, and we analyse the
impact of mutations causing autosomal recessive progeroid
syndromes of the assembly of this complex.
MATERIALS AND METHODS
Protein expression and purification
Human WT emerin fragments from amino acid 1 to amino
acid 187 (EmN), from amino acid 67 to 170 (EmC170),
from amino acid 67 to 187 (EmC187) and from amino acid
67 to amino acid 221 (EmC), human BAF with all cys-
teines mutated in alanine and human lamin B1 tail from
amino acid 409 to amino acid 586 were expressed using a
pETM13 vector as N-terminal octa-histidine fusions in Es-
cherichia coli BL21 DE3 Star (Novagen). The emerin and
BAF cDNAs were optimized for expression in Escherichia
coli (Genscript). Human wild-type lamin A/C fragment
from amino acid 411 to amino acid 566 (LamIgF) was ex-
pressed using a pGEX vector as an N-terminal GST fu-
sion in E. coli BL21 DE3 Star (Novagen). All LamIgF mu-
tant expression vectors (R435C, R453W, R471C, R482W,
R527H, A529V and K542N) were obtained by mutagen-
esis using the Quikchange (Agilent) kit from the LamIgF
expression vector. Bacteria were cultured in rich medium
(lysogeny broth, LB) or 15N-labeled minimum medium, in-
duced at an optimal density of 1 with 0.5 mM isopropyl -
D-1-thiogalactopyranoside, grown overnight at 293 K, and
lysed in 50 mM Tris–HCl pH 8.0, 300 mM NaCl, 40 mM
imidazole, 5% glycerol, 1% Triton X-100 and 1 mM phenyl-
methanesulfonylfluoride.
For EmN, EmC170, EmC187, EmC and BAF, after son-
ication at room temperature and centrifugation at 20 000 g,
for 20min, at 277K, the pellet was resuspended in buffer C8
(50mMTris–HCl pH8.0, 150mMNaCl, 20mM imidazole,
8 M urea). A second centrifugation step was performed at
20 000 g, for 20 min, at 293 K. The soluble extract was then
loaded onto Ni-NTA beads (GE-Healthcare) equilibrated
with buffer C8. Proteins were eluted directly with buffer E8
(50 mM Tris–HCl pH 8.0, 150 mMNaCl, 1 M imidazole, 8
M urea). Then, proteins were refolded by dialysis in buffer
D1 (20 mM Tris–HCl pH 8.0, 30 mM NaCl, 2 mM DTT)
for EmN, EmC170, EmC187 and EmC and buffer D2 (50
mM Tris–HCl pH 8.0, 150 mMNaCl, 2 mMDTT) for BAF.
After refolding, they were incubated with the TEV protease
during 3 h at room temperature and finally dialyzed into the
selected buffer. The final yield was typically 10 mg of puri-
fied protein per liter of bacterial culture (26). Self-assembly
was initiated using proteins that were dialyzed in a buffer
containing 20 mM Tris–HCl pH 8.0 and 30 mMNaCl. Af-
ter dialysis, proteins were concentrated until 600 M, re-
duced with 5 mM DTT and stored at room temperature
during one week.
For lamin B1 tail, after sonication at 277 K, benzonase
(SigmaAldrich) addition and centrifugation at 20 000 g, for
30 min, at 277 K, the soluble extract was loaded onto Ni-
NTA beads (GE-Healthcare) equilibrated with buffer C (50
mM Tris–HCl pH 8.0, 150 mM NaCl and 20 mM imida-
zole). The protein was then eluted directly with buffer E (50
mM Tris–HCl pH 8.0, 150 mM NaCl and 1 M imidazole)
and dialyzed in buffer C. It was incubated with the TEV
protease during 3 h at room temperature, loaded again onto
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Ni-NTA beads and finally, after flow-through recovery, di-
alyzed into the selected buffer. The final yield was typically
20 mg of purified protein per liter of bacterial culture.
For LamIgF (WT and mutants), after sonication at 277
K, benzonase (SigmaAldrich) addition and centrifugation
at 20 000 g, for 30 min, at 277 K, the soluble extract was
loaded onto GST-beads (GE-Healthcare) equilibrated with
buffer T2 (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 2 mM
DTT). After 2 h of incubation at 277 K, GST-beads were
washed with buffer T2 and 1 M NaCl, and then throm-
bin was added and incubated with the beads overnight. The
protein was recovered in the flow-through and finally dia-
lyzed into the selected buffer. The final yield was typically 2
mg of purified protein per liter of bacterial culture.
Liquid-state NMR spectroscopy
NMR experiments were performed on a 700 MHz Bruker
Avance spectrometer equipped with a triple resonance cryo-
genic probe. To study interaction between the lamin frag-
ments and BAF, two-dimensional 1H–15N HSQC spectra
were acquired at 303 K, on a 3-mm-diameter NMR sam-
ple tube containing 100–200 M uniformly 15N-labeled
lamin peptides and non-labeled BAF, in 20 mM sodium
phosphate pH 7.0, 100 mM NaCl and 80:20% H2O/D2O.
To study the interaction between lamin fragments and
EmN or EmC, two-dimensional 1H–15N HSQC spectra
were acquired at 303 K, in a 3-mm-diameter NMR sam-
ple tube containing 150 M uniformly 15N-labeled lamin
peptides and non-labeled EmN or EmC, in 20 mM Tris–
HCl pH 8.0, 30 mM NaCl and 80:20% H2O/D2O. The
1H, 15N, 13C NMR signals of lamin A/C domain from
aa 411 to aa 553 were already assigned previously in a
phosphate buffer at pH 6.3 and 303 K (27). In order
to assign the NMR signals of lamin A/C region from
aa 411 to aa 566 (LamIgF) in our conditions (20 mM
sodium phosphate pH 7.0, 100 mM NaCl, 303 K), we
took advantage of these previous assignments, but also
recorded additional 3D 1H–15N–13C correlation spectra us-
ing 3D HNCACB, CBCA(CO)NH, HNCO, HN(CA)CO
andHN(CO)(CA)NHpulse sequences on a 3-mm-diameter
NMR sample tube containing 500 M uniformly 15N/13C-
labeled LamIgF. The data were processed using Topspin3.1
(Bruker) and analyzed using CCPNMR (28).
Size-exclusion chromatography
Size-exclusion chromatography experiments aiming at iden-
tifying interactions between emerin, BAF and lamin frag-
ments (LamIgF WT and mutants, lamin B1 tail) were
performed using a Superdex-75 10/300 GL column (GE
Healthcare) pre-equilibrated with buffer G (20 mM Tris–
HCl pH 8.0, 30 mMNaCl, 2 mMDTT). 500 l of proteins
concentrated at 150 M were injected for each experiment
at a flow rate of 0.5 ml/min at 277 K.
Isothermal titration calorimetry
ITC was performed using a high-precision VP-ITC
calorimetry system. To characterize interactions between
the BAFdimer and LamIgF (WT andmutants), all proteins
were dialyzed against 50 mM Tris–HCl pH 8.0, 150 mM
NaCl, 10 mM -mercaptoethanol and protease inhibitors
(Roche). BAF (20 M) in the calorimetric cell at 288 K
was titrated with LamIgF WT (at a concentration of 100
M in the injection syringe) or BAF in the calorimetric cell
at 283 K was titrated with LamIgF mutants (at a concen-
tration of 100 M in the injection syringe). To characterize
interactions between the BAF dimer and EmN, all proteins
were dialyzed against 50 mM Tris–HCl pH 8.0, 150 mM
NaCl, 10 mM -mercaptoethanol and protease inhibitors
(Roche). BAF (30 M) in the calorimetric cell at 288 K
was titrated with EmN (at a concentration of 150 M in
the injection syringe). Analyses of the data were performed
using the Origin software provided with the instrument.
Negative-staining electron microscopy
To observe self-assembled EmN and EmC proteins, with
or without LamIgF WT or lamin B1 tail, protein sam-
ples containing 2% uranyl acetate were deposited on glow-
discharged carbon-coated copper grids. Data collection was
performed using a Tecnai Spirit transmission electron mi-
croscope (FEI) equipped with a LaB6 filament, operating
at 100 keV. Images were recorded using a K2 Base camera
(Gatan, 4k × 4k) at 15 000 magnification (at the level of
the microscope) with a pixel size of 0.25 nm at the specimen
level.
X-ray crystallography
Crystallization and data collection. The EmN-Baf-
LamIgF complex was purified by gel filtration (Superdex
75, 10/300 GL) in 50 mM Tris–HCl pH 8.0, 100 mM
NaCl and concentrated to 3 mg/ml. Crystallization was
initiated one week after the gel filtration and in these
conditions, EmN was proteolyzed and the final complex
was composed of LEM-BAF-LamIgF. For crystallization,
1 l of the complex was mixed with 1 l of the reservoir
solution and equilibrated against a 500-l reservoir by
hanging drop at 277 K. Crystals were grown in 25% (w/v)
polyethylene glycol (PEG) 3.350, 20 mM Bis-Tris pH 5.5,
30 mM NaCl and 0.2 M NH4SO4. They were flash-cooled
in liquid nitrogen, using a cryo-protection solution of 25%
PEG 3.350, 20 mM Bis-Tris pH 5.5 and 0.2 M NH4SO4,
supplemented with 27% (V/V) ethylene glycol.
Structure determination and refinement. The 3D structure
of the complex was solved by molecular replacement using
Molrep in CCP4 (29,30). The coordinates of the BAF dimer
with DNA (PDB entry: 2BZF), the coordinates of lamin
A/C globular domain (PDB entry 1IFR) and the coordi-
nates of the emerin LEM domain (PDB entry: 2ODC) were
used as templates. The resulting model was rebuilt using
PHENIX suite (31), manual correction was performed with
Coot (32) according to |Fo| – |Fc| and 2|Fo| – |Fc| electron
density maps, and further refinement was carried out with
phenix.refine. All structure figures were prepared using Py-
MOL (Schro¨dinger, LLC). Structure coordinates were de-
posited to the PDB, with entry 6GHD.
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Fluorescence-based thermal shift assay
The thermal stability of LamIgF proteins was monitored
by a fluorescence-based thermal shift assay performed with
a QuantStudio 12K Flex instrument (LifeTechnologies). 10
g of purified protein was mixed with the SYPRO Orange
dye (diluted 800-fold from a 5000-fold stock solution, In-
vitrogen) in 50 mM Tris pH 8.0, 150 mM NaCl, 10% glyc-
erol. Reactions were carried out in duplicate in a 96-well
fast PCR plate at a final volume of 20 l (33 M) and each
experiment was repeated at least twice independently. The
samples were submitted to a denaturation kinetic from 283
to 368 K at a rate of 3 K/min and fluorescence of Sypro
Orange dye was recorded in real time. The protein denat-
uration temperature (Td ± s.e.m.) was calculated using the
Protein Thermal Shift software v1.3 (LifeTechnologies) as
the maximum of the derivative of the resulting fluorescence
curves.
Proximity ligation assays
Transfection. HeLa cells were obtained from American
Type Culture Collection and cultured in Minimum Es-
sential Medium containing Glutamax (Gibco), 1% non-
essential amino acids and 10% fetal bovine serum. HeLa
cells were transfected using XtremeGene 9 (Roche) with
the plasmids pEGFC3-BAF encoding full length BAF and
pcmvTAG2A-FLAG-Lamin A encoding mature lamin A
(aa 1-646). After 24 h, cells were processed for either im-
munoblotting, immunofluorescence or Proximity ligation
assay.
Immunoblotting. Whole cell protein extracts were sus-
pended in Laemmli sample buffer, separated by SDS-PAGE
and transferred to nitrocellulose membranes. Membranes
were blocked for 1.5 h in TBST (10 mM Tris pH 8.0, 150
mM NaCl, 0.05% Tween-20) containing 5% dry milk, in-
cubated with mouse anti FLAG antibody (Sigma; 1:600)
and rabbit anti-BAF (Santacruz, 1:200) for 1 h in TBST/1%
milk, washed 4 times and incubated with HRP-conjugated
secondary antibodies. After four washes in TBST, proteins
were detected by enhanced chemiluminescence.
Immunofluorescence microscopy. Cells were fixed with 3%
paraformaldehyde for 12 min at R.T., permeabilized with
phosphate buffered saline containing 0.5% Triton for 5 min
at R.T., and quenched with 2% bovine serum albumin di-
luted in phosphate buffered saline containing 0.1% Tri-
ton. Primary antibodies were rabbit anti-FLAG (Sigma,
1:300) and mouse anti-GFP (Roche, 1:200). Fluorescent la-
beled secondary antibodies (donkey anti-mouse Cy2 1:60
and donkey anti-rabbit 594 1:200) were from Jackson Im-
munoResearch. DNA was stained with Hoechst 33258 (1
g/ml).
Proximity ligation assay. PLA was used to detect interac-
tions betweenGFP-BAF andFLAG-laminA, eitherWTor
mutant (R435C,R527H,A529V,K542N,R453W,R482W),
based on proximity (<40 nm) of two secondary antibod-
ies directed against these tagged proteins. After cell fixa-
tion, cell permeabilisation and quenching (as above), pairs
of primary antibodies, rabbit anti-FLAG 1:300 and mouse
anti-GFP 1:200, were added onHeLa cells expressingGFP-
BAF together with FLAG-laminA, for 40min atR.T.Next,
Duolink PLA probe anti-rabbit plus, Duolink PLA probe
anti-mouse minus and Duolink detection reagents orange
(detected with a Cy3 filter) were used according to manu-
facturer’s instructions (Olink, Bioscience). At last, cells were
mounted in Duolink mounting medium with Dapi (Olink,
Bioscience). Confocal microscopy image acquisition was
performed using a LSM 700 Laser scanning microscope
(Zeiss) at the imaging facility of the BFA institute. Quanti-
tative analysis of PLA signals was done on images using Im-
ageJ, as reported in (33). Data were then analyzed by com-
paringmedian values for the total number of pixels showing
a signal (Cy3) per nucleus. Data of the three independent
experiments were normalized to 1 (100%) for cells express-
ing FLAG-lamin AWT. Statistical analysis were performed
using Kruskal–Wallis tests.
RESULTS
The lamin A/C Igfold domain interacts with the self-
assembled emerin fragment EmN
To determine how the lamin A/C tail interacts with emerin,
we generated two fragments of the emerin nucleoplasmic re-
gion (Figure 1A). We tested binding between the tail region
common to lamins A and C (LamIgF comprising aa 411
to aa 566) and these emerin fragments. As previously pub-
lished, the whole emerin nucleoplasmic region from aa 1 to
aa 221 is poorly soluble (34).We thus produced two overlap-
ping emerin peptides, which we called EmN (26) and EmC
(Figure 1A). EmN (aa 1 to aa 187) comprises a LEM do-
main and a region that is intrinsically disordered (34,35).
We previously showed that, in vitro, it can be observed ei-
ther as a monomer or as an oligomer (26) (Figure 1B, left
panel). EmC (aa 67 to aa 221) is entirely unstructured as
observed by NMR (Supplementary Figure S1A), and after
purification immediately oligomerizes as observed by fluo-
rescence (Supplementary Figure S1B) and negative-staining
electron microscopy (EM; Figure 1B, right panel). In order
to identify an interaction between lamin A/C and emerin,
we produced a 15N labeled LamIgF peptide, and mixed the
labeled peptide with either monomeric EmN, oligomeric
EmN or oligomeric EmC (Figure 1C). The oligomeric state
of emerin fragments in the NMR samples was systemati-
cally checked by EM (Supplementary Figure S2). Nuclear
Magnetic Resonance (NMR) analysis of these samples re-
vealed that LamIgF only interacts with oligomeric EmN in
these conditions. This interaction is specific to lamin A/C
as NMR analysis of a sample containing 15N labeled lamin
B1 tail and oligomeric EmN did not demonstrate any bind-
ing (Figure 1C, lower and right panel; the lamin A/C and
B1 Igfold domains share 52% of sequence identity).
The Igfold domain of lamin A/C forms a ternary complex
with the LEM domain of emerin and BAF
The chromatin-associated protein BAF binds to both lamin
A/C and emerin (36,37). We examined the role of BAF in
mediating an interaction between LamIgF, EmN and BAF
by Size-Exclusion Chromatography (SEC). Consistent with
our previous NMR results, we observed that LamIgF and
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Figure 1. The lamin A/C Igfold domain directly binds to emerin self-assembled nucleoplasmic region. (A) Architecture of the emerin protein, highlighting
its LEM domain (in orange) and its transmembrane domain (in dark grey), as well as the 2 fragments of the nucleoplasmic region that could be obtained as
soluble peptides (EmNand EmC). (B) Negative staining EM images of EmNand EmC fragments obtained after purification, concentration and incubation
at 293 K (white bar: 100 nm). EmN filaments were observed at 600 M after 1 week (26), whereas EmC filaments were already visible at 300 M after
1 day. The fragment corresponding to the region common to EmN and EmC did not self-assemble in these conditions (Supplementary Figure S1B). (C)
Superimposition of the solution-state NMR 1H–15N HSQC spectra of the lamin Igfold domain (lamin A/C in gray or lamin B1 in green) recorded in the
absence or presence of emerin fragments EmN or EmC (EmN in red, EmC in purple; 1:1 ratio). The emerin fragments were EmN filaments (upper left
and lower right views), EmN monomers (lower left view) and EmC filaments (upper right view). All these spectra were recorded at 303 K on a 700 MHz
spectrometer.
monomeric EmN did not co-elute under the conditions
used (Figure 2A). However, they co-eluted in the presence
of BAF. Similarly, we tested the binding between the lamin
B1 tail fragment, EmN and BAF. In this case, no binding
could be observed between lamin B1 and BAF, precluding
the formation of a ternary complex with EmN. NMR fur-
ther confirmed that the lamin B1 tail fragment did not inter-
act with BAF (Supplementary Figure S3). Isothermal Titra-
tion Calorimetry (ITC) experiments showed that LamIgF
and EmNbind to BAFwith an affinity of 3.2± 1.2Mand
0.7 ± 0.2 M, respectively (Figure 2B). The LamIgF/BAF
interaction is enthalpy driven, whereas the EmN / BAF in-
teraction is both enthalpy and entropy driven (Supplemen-
tary Table S1). Crystal structure of the ternary complex was
solved at 1.9 A˚ resolution (Figure 3A; Supplementary Table
S2). One BAFdimer interacts on one side with the LEMdo-
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Figure 2. The lamin A/C Igfold domain binds to emerin monomeric LEM domain through BAF. (A) Detection of a ternary complex including LamIgF,
EmN and BAF by size exclusion chromatography using a Superdex 75 10/300GL column. Each gel corresponds to the elution of a different set of proteins,
using the same column, the same protein concentrations and the same buffer: from the bottom EmN, LamIgF, BAF, lamin B1 tail (LB1; the lower band
corresponds to a degradation product), BAF and lamin B1 tail, EmN and LamIgF, EmN and BAF, LamIgF and BAF and finally EmN, LamIgF and
BAF. The bands corresponding to the different complexes are boxed: EmN and BAF in orange, LamIgF and BAF in green and the ternary complex in
blue. (B) ITC titration of BAF onto LamIgF (upper panel) and BAF onto EmN (lower panel). 200 MLamIgF or EmN were injected in a cell containing
40 M of BAF at a temperature of 288 K. The affinities deduced from the fitting are 3.2 ± 1.2 M and 0.7 ± 0.2 M, respectively. The corresponding
thermodynamics parameters (in kcal/mol) are plotted in the low right corner of the ITC figures.
main of emerin and on the other side with the Igfold domain
of laminA/C. The emerin fragment outside of the LEMdo-
main is not visible in the electron density map. SDS-PAGE
revealed that it was proteolyzed between protein purifica-
tion and crystallization.
Dimerization of BAF is essential for both lamin and emerin
binding
The 3D structure of the ternary complex highlights that
BAF dimerization is essential for emerin and lamin A/C
binding. First, BAF monomers 1 and 2 both interact
with the LEM domain of emerin (interfaces of 395 and
211 A˚2, respectively) (Figure 3B). BAF monomer 1 loop
23 (Phe39), helix 3 (Gln48, Val51, Leu52) and helix
4 (Leu58, Glu61, Trp62) contact a LEM surface compris-
ing the -strand (Gly24, Pro25), loop 12 (Ser29, Thr30)
and helix 2 (Leu33, Tyr34, Lys36, Lys37). BAF monomer
2 loop 23 (Arg37, Phe39) and helix 3 (Glu48) contact
an overlapping LEM surface comprising helix 1 (Thr13),
the -strand (Pro25) and loop 12 (Val27). A similar
3D structure between BAF dimer and emerin LEM do-
main was previously modeled based on NMR data (Figure
3C; PDB reference 2ODG (19)). When we superimposed
the C atoms of the 2 structures, we obtained root mean
square deviation values of 1.3, 1.4 and 0.9 A˚ for the LEM
domain, BAF monomer 1 and BAF monomer 2, respec-
tively, demonstrating that the NMR and X-ray structures
are highly similar. If we superimposed only the C atoms
of dimeric BAF, we measured a root mean square devia-
tion of 2.8 A˚ between the LEM domains of the 2 structures.
Consistently, the surface buried at the LEM/BAF interface
yielded 510 A˚2 in theNMR structure compared to 606 A˚2 in
the X-ray structure. Altogether, we observed a slightly dif-
ferent positioning of the LEM domain onto the BAF dimer
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky736/5076365 by D
aw
son France (C
E D
BC
M
 SAC
LAY) user on 17 Septem
ber 2018
Nucleic Acids Research, 2018 7
Figure 3. Three-dimensional structure of the complex between LamIgF, emerin LEM domain and BAF. (A) Cartoon representation of the complex, with
emerin LEM domain (residues 3–44) in orange, BAF dimer in yellow-green and green (residues 4–89), and lamin A/C Igfold domain (residues 432–544) in
gray. The interfaces corresponding to the emerin / BAF and BAF / lamin interactions are indicated by red circles and numbered as 1 and 2, respectively.
(B) Superimposition of the 3D structure of the BAF dimer bound to the emerin LEM domain, as determined in this work (same colors as in (A)), and as
revealed using NMR by Clore et al. (PDB reference 2ODG (19); in cyan). (C) Zoom on the EmN/BAF interface, with residues >30% buried within the
interface displayed in sticks. On the emerin side, the interface is mainly formed by residues Gly24 to Lys37 (labeled residues on loop 12 and helix 2).
On the BAF side, it is mainly formed by helices 3 and 4 of one monomer and loop 23 and helix 3 of the other monomer.
and a consistent larger surface complementarity in the X-
ray structure.
Both BAFmonomers also contribute to laminA/Cbind-
ing, through interfaces of 270 and 192 A˚2, respectively (Fig-
ure 4A). BAF monomer 1 helix 1 (Val11, Ala12), loop
12 (Pro14) and helix 5 (Glu83, Ala87, Phe88) contact
lamin A/C strand 1 (His433, Ala434, Arg435) and strand
9 (Met540, Lys542), whereas BAF monomer 2 helix 1
(Ala12), loop 12 (Pro14) and helix 5 (Ala87, Phe88)
contact lamin A/C strand 1 (Arg435) and loop 89
(Glu537). It was reported that BAF mutant G47E lost its
ability to bind to lamin A as well as prelamin A in cells (5).
Gly47 is located at the center of the dimerization interface
(in magenta on Figure 4A). Mutation G47E might desta-
bilize the BAF dimer, therefore hindering BAF interaction
with both emerin LEM domain and lamin A/C Igfold.
The interface between lamin A/C and BAF involves residues
mutated in progeroid syndromes
By solving the 3D structure of a ternary complex formed
by BAF, EmN and LamIgF, we revealed a yet undescribed
interface between the BAF dimer and the lamin A/C Igfold
domain. On the BAF side, Ala12, Pro14 and Phe88 of both
monomers are more than 50% buried in the complex (Fig-
ure 4A). An Ala12 to Thr amino acid substitution occurs in
patients with a Nestor-Guillermo progeria syndrome (38).
Our 3D structure predicts that this substitution causes a de-
fect in BAF/lamin binding. Consistently, in cells, it signif-
icantly decreases BAF binding to lamin A and prelamin A
(5).
On the lamin side, Arg435, Met540 and K542 are more
than 50% buried at the lamin/BAF monomer 2 inter-
face (Figure 4A). Arg435 side-chain is hydrogen-bonded to
Phe88 backbone oxygens of both BAF monomers, while
Lys542 side-chain is bonded to BAF monomer 2 Asp86
backbone oxygen. These lamin residues are mutated in pa-
tients with severe autosomal recessive progeroid syndromes
(RD and HGPS (14,39–43)). They belong to a hot spot
for mutations causing progeroid diseases (14). In order to
verify that in solution, this hot spot surface is contacting
BAF, we followed the NMR 1H and 15N signals of LamIgF
while adding BAF to the NMR sample. We observed that
the intensities of the NMR signals corresponding to several
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Figure 4. Lamin A/C Igfold domain binds BAF through a -sheet includ-
ing residues mutated in recessive progeroid syndromes. (A) Cartoon rep-
resentation of the complex between the lamin A/C Igfold domain and the
BAF dimer (main chain colors as in Figure 3). On the lamin side, the in-
terface is mainly polar: it is formed by residues His433, Ala434, Arg435,
Glu537, Met540 and Lys542 (in red sticks). On the BAF side, it is formed
by residues from helix 1, loop 12 and helix 5 from both monomers.
At the BAF monomer-monomer interface, Gly47 is displayed in magenta.
(B) 1H–15N HSQC spectrum of LamIgF (150 M) in the absence (grey)
and presence (green) of BAF (150 M) (ratio: 1 LamIgF for 0.5 BAF
dimer). The labelled peaks exhibit a significant intensity decrease after ad-
dition of BAF. The peaks labelled in italics correspond to residues mutated
in patients with progeroid diseases (R435(39,40),(42), R471C (44), M540
(43),(14), K542 (41)).
residues of strand 1 (as Arg435), loop 12, strand 4 (as
Arg471), loop 89 and strand 9 (as Met540 and Lys542)
were significantly decreased (Figure 4B). This demonstrated
that the -sheet formed by strands 1 and 9 is indeed in-
volved in BAF binding in solution.
Lamin A/C Igfold mutations causing progeroid syndromes
decrease binding affinity for BAF
To identify the consequences of the LamIgF mutations
causing progeroid diseases on the formation of the lamin-
BAF complex, we produced a set of LamIgF peptides mu-
tated on sites responsible for severe diseases. We focused
our interest on five homozygous LamIgFmutations, R435C
(strand1) (39,40,42), R471C (strand4) (44), R527H (45–
48), A529V (49) (strand 8) and K542N (strand 9) (41),
which were identified in patients with atypical progeroid
syndromes. Two of these mutations cause syndromes gen-
erally appearing during early childhood as RD (R435C)
andHGPS (K542N), characterized by severe premature ag-
ing features, whereas mutations R471C, R527H andA529V
cause a disease generally appearing later, calledMAD, char-
acterized by growth retardation and skeletal abnormalities.
In the case ofR471C, the diseasewas particularly severe and
the phenotype combined MAD, progeria, and rigid spine
muscular dystrophy (44). We also produced as control vari-
ants the mutants R453W and R482W that cause Emery-
Dreifuss Muscular Dystrophy (EDMD) and Dunnigan-
type Familial Partial Lipodystrophy (FPLD), respectively.
We first verified that the LamIgF mutated peptides were
well folded and had a thermal stability close to that of WT
LamIgF (i.e. ±5 K relatively to WT; Supplementary Fig-
ure S4; see also the X-ray structure of mutant R482W in
(50)). We then measured their affinity for BAF by ITC (Fig-
ure 5A; Supplementary Table S1). We observed that the 2
control mutants R453W and R482W bind BAF as LamIgF
WT, whereas mutant R435C does not bind BAF in our con-
ditions. Mutants R471C and A529V exhibit a 5-fold de-
creased affinity for BAF. In the case of K542N and R527H,
the heat release due to BAF binding was so weak that no
affinity could be measured. We also tested the binding of
LamIgFmutants to BAF by SEC (Figure 5B). We observed
that mutants R453W and R482W coeluted together with
BAF as WT LamIgF. However, mutant R435C did not in-
duce any elution volume shift of BAF, and mutants R471C,
A529V, R527H and K542N only weakly shifted BAF elu-
tion volume. We concluded that the five tested mutations
causing atypical progeroid syndromes decrease the affinity
of lamin A/C for BAF. Moreover, the binding defect seems
to globally correlate with the disease severity (Figures 5A
and B).
Finally, we transfected HeLa cells with plasmids coding
for GFP-BAF and FLAG-mature lamin A (aa 1 to aa 646)
WT or variants and detected using an in situ Proximity Lig-
ation Assay the proximities between BAF and lamin A in
these cells.We thus tested the impact of mutations related to
RD (R435C),HGPS (K542N) andMAD (R527H,A529V),
as well as EDMD (R453W) and FPLD (R482W), on these
proximities. FLAG-lamin variants were expressed at simi-
lar protein levels as FLAG-lamin WT; they localized both
at the nuclear periphery and in the nucleoplasm (Figure 6A
and B). We observed that all 4 lamin A mutations associ-
ated with atypical progeroid syndromes similarly reduced
the frequency of the proximity events between BAF and
lamin A (Figures 6C and 7). Lamin A mutations associ-
ated with muscle and adipose tissue diseases had an inter-
mediate impact: they also reduced the number of proximity
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Figure 5. Impact of mutants causing recessive progeroid syndromes on BAF binding depends on the disease severity. (A) ITC titration of BAF onto
LamIgF, as measured at 283K. Whereas variants R453W and R482W showWT binding, variants A529V and R471C exhibit a significantly lower binding
enthalpy and affinity as compared to LamIgFWT. No affinity could be measured for R527H and K542N and no binding could be detected for R435C. In
the lower right panel, the spatial distribution of residues mutated in (A) is displayed on the lamin A/C Igfold structure (PDB reference 1IFR (12)). The two
residues mutated in control variants, causingmuscle and adipose tissue diseases respectively, are colored in green, whereas the 5 residues mutated in variants
with a lower affinity for BAF are colored in cyan, purple and red (for weak binding, no measurable affinity and no detected binding, respectively). (B) Size
exclusion chromatography of LamIgF mutants mixed to BAF (Superdex 75 10/300GL). Each gel corresponds to the elution of a different set of proteins,
using the same column, the same concentrations and the same buffer: from bottom BAF, BAF and R435C, BAF and K542N, BAF and R527H, BAF and
R471C, BAF and A529V, BAF and R482W, BAF and R453W and BAF and WT LamIgF. The bands corresponding to the BAF-LamIgF complex are
boxed in red.
events but their impact was significantly lower than the im-
pact of mutations associated with progeroid syndromes in
cells (Figures 6C and 7).
DISCUSSION
The mechanical roles of lamins and their functions in gene
regulation are often viewed as independent activities, but re-
cent findings suggest a highly cross-linked and interdepen-
dent regulation of these different activities (51–53). Lamins
interact with inner nuclear membrane proteins to mediate
mechanical signaling but also contact chromatin-associated
proteins that contribute to gene transcription regulation.
Most of these interactions depend on the lamin ability to
assemble into higher-order structures (54,55). Therefore,
lamin assembly has been studied intensively in vitro and the
resulting filaments have been observed in cells (11). In con-
trast, little is known about the contacts of lamins with their
partners in vivo. Lamins are extensively modified and inter-
act with a large number of proteins (56,57), the inner nuclear
membrane (58) and chromatin (59). Their tail region is re-
sponsible for association with partners. It contains a glob-
ular Igfold domain that is mutated in several laminopathies
(13). Until this study, it was not known how this domain in-
teracted with partners anchored at the inner nuclear mem-
brane and established contacts with chromatin.
The laminA/C Igfold domain directly binds to self-assembled
emerin but also indirectly interacts with monomeric emerin
through BAF
We showed that the laminA/C Igfold domain interacts with
the inner nuclear membrane protein emerin through two
mechanisms: it either directly binds to self-assembled EmN
or interacts indirectly with monomeric EmN through the
chromatin-associated protein BAF. It was previously pub-
lished that direct lamin A tail interaction with emerin is
disrupted not by mutations in the LEM domain, but by
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Figure 6. Mature lamin mutants with mutations causing recessive progeroid syndromes impair BAF binding in cells. (A) HeLa cells expressing GFP-BAF
(WT) together with either WT, R435C, R527H, A529V, K542N, R453W or R482W FLAG-LAm were fixed, and processed for immunofluorescence using
as primary antibodies, a mix of anti GFP and anti-FLAG antibodies. Observation was done at the confocal microscope. Are shown in the left panels,
merges for GFP-BAF (green), FLAG-LAm (red) and DNA (blue), and in the right panels, the FLAG-LAm alone. Scale bar: 20 m. (B) Whole cell
protein extracts prepared from HeLa cells control (ctrl) or expressing GFP-BAF (WT) together with either WT, R435C, R527H, A529V, K542N, R453W
or R482W FLAG-LAm were analyzed by western blot using anti FLAG and anti BAF antibodies. (C) HeLa cells expressing GFP-BAF (WT) together
with either WT, R435C, R527H, A529V, K542N, R453W or R482W FLAG-LAm were fixed, labeled with a mix of anti GFP and anti-FLAG antibodies
and further processed for PLA before observation at the confocal microscope. The PLA signals (red) are shown merged with DNA (blue) and GFP-BAF
(green) or alone (PLAssay). Signals for GFP-BAF and DNA are shown alone in the two right panels, respectively. Scale bar: 15 m.
mutations in emerin region from aa 70 to aa 164: muta-
tions around positions 70, 76, 95, 112, as well as 141 and
164, decreased binding of lamin A to emerin (15,37). These
results are consistent with our analysis. Indeed, the disor-
dered region of emerin between aa 50 and aa 132 is neces-
sary for emerin self-assembly (26) and LamIgF only binds
directly to self-assembled emerin. Similarly, GST fusions
of an emerin fragment from aa 1 to aa 132 is sufficient to
bind mature lamin A tails (18), and we showed that emerin
aa 1 to aa 132 is sufficient for self-assembly (26). Finally,
the EDMD-associated emerin deletion mutation del95-99,
which impairs EmN self-assembly in vitro, causes a decrease
of lamin A/C binding in cells (26). Altogether these results
strongly suggest that emerin self-assembly is necessary for
direct binding to lamin A/C in cells. On the other hand,
we showed that the monomeric LEM domain (emerin aa 1
to aa 45) indirectly interacts with the lamin A/C Igfold do-
main through a dimer of BAF, consistent with previous data
showing that BAF enhanced binding of prelamin A tails to
emerin (24).
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Figure 7. Quantification of the decrease in proximity events between mature lamin A and BAF due to mutations causing either recessive progeroid syn-
dromes, EDMD or FPLD. Quantification of PLA signals per nucleus was performed as reported in (33). (A) Proximity events were compared between
either WT lamin A and BAF, or lamin A variants associated with progeroid syndromes and BAF. (B) The impact of lamin mutations causing either a
progeroid syndrome (R435C), EDMD (R453W) or FPLD (R482W) on the proximity between mature lamin A and BAF was measured. The upper graphs
show the results of three independent experiments carried out with each mutant. The lower graphs represent the mean values± stdevpa (n= 3 experiments;
*P < 0.05 with Kruskal and Wallis test).
A defect at the interface between lamin A/C and the
chromatin-associated BAF protein is observed in atypical
progeroid syndromes
By analyzing the 3D structure of our ternary complex com-
prising domains of lamin A/C, BAF and emerin, we no-
ticed that the interface between lamin A/C and BAF co-
incides with a hot spot of lamin A/C residues mutated in
progeroid syndromes (14). Proximities between lamin A/C
and BAF were detected in situ using a proximity assay; they
were particularly enriched at the nuclear periphery in HeLa
cells (Supplementary Figure S5). The four tested mutations
associated with progeroid syndromes reduced the frequency
of proximity events between lamin A and BAF. This de-
crease was significantly larger than the decrease observed
in the case of control mutations R453W and R482W asso-
ciated with muscle and adipose tissue diseases, respectively:
mutations associatedwith progeroid syndromes reduced the
number of PLA signals to ∼50% of the signals measured
for WT lamin A and BAF. Consistently, in vitro, SEC ex-
periments revealed that LamIgF mutants R471C, A529V,
R527H and K542N weakly interact with BAF, and mutant
R435C does not bind BAF. ITC experiments provided only
estimations for affinity decreases, due to the weak affini-
ties of the mutants. However, an affinity decrease of∼5-fold
could be calculated formutantsR471C andA529T, whereas
essentially no binding could be detected for R527H,K542N
and R435C. Interestingly, this affinity scale matches with
the severity of the associated diseases: R471C and A529V
cause MAD that generally appears during late childhood
(44,49), whereas K542N causes a HGPS with an onset be-
tween 18 and 24 months (41) and R435C causes the most
severe disease, RD, which appears during the first months
after birth (39,40,42); only mutant R527H, which causes a
MAD (45–48), also shows a strong BAF binding defect un-
der the conditions we used. We conclude that a destabiliza-
tion of the interface between lamin A/C and BAF might
mediate the disease-mechanism in atypical progeroid syn-
dromes due to homozygous mutations in LamIgF.
Another progeroid syndrome called the Nestor-
Guillermo Progeria Syndrome occurs in patients older
than the average lifespan of progeroid patients. This
syndrome is due to the homozygous BAF mutation A12T
(38). The mutated protein is expressed and stable (60).
In cells, it still co-immunoprecipitates with endogeneous
emerin, lamin A and histone H3. Our preliminary data
show that, in vitro, mutation A12T does not compromise
BAF 3D structure (Supplementary Figure S6A), and BAF
mutant A12T interacts with LamIgF, but with an affinity
lower than BAFWT and BAF S4E (Supplementary Figure
S6B). Immunoprecipitation experiments performed in
co-transfected cells also showed a reduced interaction
between BAF mutant A12T and lamin A (5). Finally, BAF
mutant A12T exhibited a marked defect in double-stranded
DNA binding compared to WT BAF (60). Altogether,
these data strongly suggest that the complex between
BAF, lamin A/C, DNA and emerin is destabilized by the
mutation A12T, highlighting the similarity between the
mechanisms of autosomal recessive progeroid syndromes
due to mutations in LamIgF and BAF.
Complexes including lamin A/C and emerin are assembled at
different stages of the cell cycle
In cells, formation and localization of complexes in-
cluding lamin A/C, BAF and emerin is highly regu-
lated and depend on the cell cycle, in accord with the
disassembly/reformation of the nuclear envelope that de-
limits the interphase nuclear compartment. We have iden-
tified two types of complexes including lamin A/C and
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Figure 8. A first model of the interface between the LEM-domain proteins, the nucleoskeleton and the chromatin-associated protein BAF. (A) During the
ana/telophase, BAF mediates an interaction between the lamin A/C Igfold domain and emerin anchored at the endoplasmic reticulum (ER) or at the
inner nuclear membrane (INM). Superimposition of the X-ray structure of the LamIgF-BAF-LEM complex onto the X-ray structure of the BAF protein
complexed to DNA (PDB reference 2BZF (62)) suggests that BAF can simultaneously interact with lamin A/C, emerin and DNA. The interface between
lamin A/C and BAF is disrupted by mutations causing autosomal recessive progeroid syndromes, as symbolized by the red arrow. (B) In interphase cells,
the lamin A/C Igfold domain binds self-assembled emerin anchored at the inner nuclear membrane (INM), as symbolized by the black arrow. It is also
able to interact with BAF and histones, thus creating an interface between the lamina and chromatin. This interface is disrupted by mutations causing
autosomal recessive progeroid syndromes, as symbolized by the red arrow.
emerin, however the biological relevance of these twomodes
of interaction is still unclear. It is known that at the end
of mitosis, in ana-telophase, first BAF, and then emerin
and lamin A/C accumulate at the core region of chromo-
somes (61). On the BAF side, mutation G25E, at the inter-
face with DNA, impairs localization of BAF at the core re-
gion of chromosomes, emerin localization during telophase
and further emerin and lamin A accumulation at reforming
nuclear envelopes. On the emerin side, the LEM domain is
necessary and sufficient for the core localization of emerin.
Superimposition of our 3D structure with that of a com-
plex between BAF dimer and DNA (PDB reference 2BZF
(62)) revealed that the BAF dimer can simultaneously bind
to emerin, lamin and DNA (Figure 8, left panel). We pro-
pose that BAFmediates the interaction between emerin and
lamin A at the core region.
In interphase cells, laminA/C is assembled into polymers
that bind to emerin (37). This interaction might not require
a well-folded LEM domain. Indeed, an emerin protein mu-
tated in its LEM domain (residues 24–27 being changed
into alanines), which does not interact with BAF (15), local-
izes normally at the nuclear envelope (63), consistent with
its ability to directly bind lamin A/C in vitro (15). We sug-
gest that lamin A/C directly interacts with emerin that is
self-assembled at the nuclear envelope (18,64) (Figure 8,
right panel). During in vitro self-assembly, emerin exhibits
a large LEM domain conformational change, strongly sug-
gesting that self-assembled emerin does not bind BAF (34).
However, we still detect proximities between laminA/C and
BAF at the nuclear periphery of interphase cells (Supple-
mentary Figure S5).
In conclusion, the Igfold domain of lamin A/C can both
directly interact with self-assembled emerin and bind to
monomeric emerin through the chromatin-associated pro-
tein BAF. A defect in the interaction between lamin A/C
and BAFmight lead to a less efficient targeting of emerin at
the reforming nuclear envelope in telophase. However, dis-
eases associated with mutations disrupting the lamin A/C–
BAF interaction are muchmore severe than diseases associ-
ated with emerin loss of function. This suggests that the im-
pact of these lamin A/C and BAF mutations goes beyond
LEM-domain protein mislocalization and loss of func-
tion. We propose that the autosomal recessive progeroid
syndrome-causingmutations perturb the BAF-mediated in-
teraction between lamin A/C and chromatin, thus lead-
ing to a dysregulation of chromatin organization and gene
expression. Consistently, an abnormal nuclear envelope–
chromatin interface was previously described using electron
microscopy in the case of progeroid syndromes caused by
lamin A or BAFmutations (5,65–67). More work is needed
to understand how the lamin–BAF complex interacts with
DNA and histones, and how a defect in this complex com-
promises the interactions between lamina and chromatin at
the nuclear periphery in autosomal recessive progeroid syn-
dromes.
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